US Patent 11135227 Oxygen linked pyrimidine derivatives

Patent 11135227 was granted and assigned to CTI BioPharma on October, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

CTI BioPharma

Current Assignee

CTI BioPharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111352270

Date of Patent

October 5, 2021

Patent Application Number

201911070

Date Filed

November 7, 2019

Patent abstract

The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to oxygen linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumours and cancers as well as other disorders or conditions related to or associated with kinases.